BECTON, DICKINSON AND COMPANY Chart calendar Becton, Dickinson and Company
e5137bae687.iiNQ3Uzhv5DSkpd6wkqh37F9lQqYC0469X-TAFTfvVE.628U5Qek0L2e-9RXtyfPqtRMoDrCJjoDjzr8SB-d9BbwFGm6Ydbxxp_E3g~0834800d234283c4c7f2e508e959e5e1
Upcoming events on Becton, Dickinson and Company
Past events on Becton, Dickinson and Company
| 2024-05-14 11:00 | BofA Securities Health Care Conference |
| 2024-05-02 08:00 | Q2 2024 Earnings Call |
| 2024-05-02 06:30 | Q2 2024 Earnings Release |
| 2024-03-13 09:30 | Barclays Global Healthcare Conference |
| 2024-03-06 | Ex-dividend day |
| 2024-02-29 08:00 | Citi Unplugged Medtech and Life Sciences Access Day |
| 2024-02-26 15:00 | Next Installment of BD Innovates Conference |
| 2024-02-01 08:00 | Q1 2024 Earnings Call |
| 2024-02-01 06:30 | Q1 2024 Earnings Release |
| 2024-01-23 13:00 | Annual General Meeting |
| 2024-01-09 10:30 | JPMorgan Healthcare Conference |
| 2023-12-11 11:30 | Business Update Call |
| 2023-12-06 | Ex-dividend day |
| 2023-11-28 08:20 | Evercore ISI HealthCONx Conference |
| 2023-11-09 08:00 | Q4 2023 Earnings Call |
| 2023-11-09 06:30 | Q4 2023 Earnings Release |
| 2023-09-12 08:50 | Morgan Stanley Global Healthcare Conference |
| 2023-09-06 | Ex-dividend day |
| 2023-09-06 08:45 | Wells Fargo Healthcare Conference |
| 2023-08-03 08:00 | Q3 2023 Earnings Call |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17 290 17 282 0.05% | 17 117 16 819 1.77% | 20 248 20 009 1.19% | 18 870 18 846 0.13% | 19 372 19 300 0.37% | 20 235 |
|
EBITDA Million USD | Released Forecast Spread | 5 126 5 201 -1.44% | 4 792 4 635 3.4% | 5 838 5 609 4.08% | 5 160 4 979 3.64% | 6 846 5 452 25.57% | 5 717 |
|
EBIT Million USD | Released Forecast Spread | 4 372 4 369 0.07% | 3 994 3 889 2.69% | 4 971 4 767 4.28% | 4 362 4 262 2.35% | 4 558 4 564 -0.13% | 4 883 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 163 1 862 -37.54% | 985 1 329 -25.88% | 2 242 2 509 -10.64% | 1 783 2 080 -14.28% | 1 662 2 158 -23% | 2 762 |
|
Net income Million USD | Released Forecast Spread | 1 069 1 644 -34.97% | 767 1 110 -30.92% | 2 002 2 231 -10.26% | 1 689 1 866 -9.48% | 1 424 1 936 -26.46% | 2 113 |
|
EPS USD | Released Forecast Spread | 3,89 6,07 -35.91% | 2,71 3,92 -30.89% | 6,85 7,69 -10.9% | 5,88 6,84 -14.04% | 4,94 6,59 -25.04% | 7,18 |
| Announcement Date | 05/11/19 | 05/11/20 | 04/11/21 | 10/11/22 | 09/11/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5 011 4 779 4.85% | 4 641 4 469 3.84% | 4 761 4 723 0.8% | 4 586 4 593 -0.14% | 4 821 4 668 3.28% | 4 878 4 838 0.83% | 5 087 5 020 1.33% | 4 706 4 732 -0.56% | 5 045 5 038 0.15% | 5 077 | 5 401 | 5 016 | 5 316 | 5 356 |
|
EBITDA Million USD | Released Forecast Spread | 1 362 | 1 189 1 161 2.44% | 1 344 1 246 7.85% | 1 469 1 173 25.2% | 1 293 1 230 5.1% | 1 316 1 343 -2.03% | 1 928 1 553 24.14% | 1 113 1 111 0.2% | 1 416 1 399 1.21% | 1 445 | 1 676 | 1 385 | 1 514 | 1 410 |
|
EBIT Million USD | Released Forecast Spread | 1 161 1 049 10.68% | 1 009 956 5.57% | 1 121 1 052 6.52% | 1 264 1 019 24.02% | 1 077 1 062 1.37% | 1 107 1 125 -1.64% | 1 341 1 307 2.57% | 914 922 -0.83% | 1 207 1 165 3.64% | 1 252 | 1 458 | 1 151 | 1 287 | 1 335 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 525 | 421 444 -5.18% | 321 523 -38.62% | 481 506 -4.94% | 529 539 -1.86% | 471 601 -21.63% | 181 788 -77.03% | 359 399 -10.03% | 633 622 1.77% | 709 | 914 | 579 | 772 | 823 |
|
Net income Million USD | Released Forecast Spread | 431 | 338 332 1.77% | 265 432 -38.63% | 486 360 35.04% | 438 462 -5.16% | 392 494 -20.58% | 108 572 -81.13% | 281 259 8.36% | 537 492 9.04% | 569 | 750 | 507 | 627 | 696 |
|
EPS USD | Released Forecast Spread | 1,50 3,19 -52.98% | 1,18 1,12 5.83% | 0,92 1,52 -39.27% | 1,70 1,17 45.3% | 1,53 1,68 -8.93% | 1,36 1,74 -21.84% | 0,37 1,72 -78.49% | 0,96 0,60 60% | 1,85 1,63 13.5% | 1,84 | 2,49 | 1,81 | 2,07 | |
| Announcement Date | 05/05/22 | 04/08/22 | 10/11/22 | 02/02/23 | 04/05/23 | 03/08/23 | 09/11/23 | 01/02/24 | 02/05/24 | - | - | - | - | - |
| 2024-06-13 08:00 | MESA LABORATORIES, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-06-18 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-06-26 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
| 2024-07-03 | MANI, INC.: Q3 2024 Earnings Release (Projected) |
| 2024-07-11 01:00 | GERRESHEIMER AG: Q2 2024 Earnings Release |
| 2024-07-11 | ARJO AB: Q2 2024 Earnings Release |
| 2024-07-12 01:30 | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
| 2024-07-17 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
| 2024-07-17 | MEDMIX AG: Q2 2024 Earnings Release |
| 2024-07-19 01:00 | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
Past sector events for Becton, Dickinson and Company
| 2024-05-27 16:30 | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
| 2024-05-23 06:45 | MEDTRONIC PLC: Q4 2024 Earnings Release |
| 2024-05-22 01:00 | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-17 04:19 | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 02:00 | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 2024-05-14 | HOYA CORPORATION: Q4 2023 Earnings Release |
| 2024-05-14 01:00 | AMBU A/S: Q2 2024 Earnings Release |
| 2024-05-13 | HLB CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-13 | TERUMO CORPORATION: Q4 2024 Earnings Release |
| 2024-05-13 | ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release |
